Clinical trial
A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain…
NCT00160667 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00160667 |
|---|---|
| Title | A Study Assessing Efficacy of Brivaracetam in Subjects With Persistent Pain After Shingles (Post-herpetic Neuralgia) |
| Official title | An Exploratory, Double Blind, Randomized, Placebo-controlled, Parallel Group, Multicenter Study, for the Assessment of Efficacy, Safety and Tolerability of Ucb 34714 50 mg Oral Capsules in b.i.d. Administration at the Doses of 200 mg/Day and 400 mg/Day, in Subjects (at Least 18 Years Old) Suffering… |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuralgia, Postherpetic |
| Intervention type | Drug |
| Interventions | Placebo, Brivaracetam |
| Enrollment | 152 |
| Start date | Oct 11, 2004 |
| Primary completion | Jan 5, 2006 |
| Completion | Jan 5, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 31, 2019 |
| Countries | Belgium, Bulgaria, Czechia, France, Germany, Poland, Serbia, Slovakia, Spain, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: